BioSpace News Archive

LianBio (Nasdaq: LIAN) announced today that its partner, ReViral Ltd., is expected to be acquired by Pfizer Inc. (NYSE: PFE).

Growing geriatric population worldwide and rising incidence of gastrointestinal disorders are among the key factors driving the global market revenue growth.

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), announces that Dr. Raffaele Baffa (“Dr. Baffa”) has been appointed as the Chief Medical Officer (“CMO”) of the Company, responsible for overseeing the global clinical development strategies and operations for the Company’s innovative pipeline product candidates.

Rising prevalence of chronic and infectious diseases, increasing public awareness about importance of blood donation and regular health checkups, and rising number of organ transplantations are key factors expected to drive global market growth.

During a scientific session presentation at the American Surgical Association’s (ASA) 142nd annual meeting in Chicago, Illinois, The Feinstein Institutes for Medical Research’s Matthew Weiss, MD, shared the results of a new scientific paper on diverse patient-derived organoids.

The application of this new formulation aims to aid the military in treating organophosphate poisoning in service members.

Lab Logistics Management, announced today the appointment of industry veteran Ruth Abdulmassih as Chief Executive Officer.

Agreement expands the company strategy to employ the immune system in the development of cancer therapies.

Anika Therapeutics, Inc. announced that the Company plans to issue its first quarter 2022 financial results after the close of the market on Thursday, May 5, 2022 and hold its investor conference call on the same day, at 5:00 p.m. ET to discuss its financial results and business highlights.

Curis, Inc. announced that on April 1, 2022, the independent Compensation Committee of the Board of Directors of Curis approved the grant of inducement stock options to purchase a total of 380,850 shares of Curis common stock to seven new employees, with a grant date of April 1, 2022.